Francois Nader - May 20, 2021 Form 4 Insider Report for ALEXION PHARMACEUTICALS, INC. (ALXN)

Role
Director
Signature
/s/ Douglas Barry, Attorney-in-Fact for Francois Nader
Stock symbol
ALXN
Transactions as of
May 20, 2021
Transactions value $
$0
Form type
4
Date filed
5/24/2021, 04:30 PM
Next filing
Jul 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXN Common Stock, par value $.0001 per share Award $0 +1.96K +17.38% $0.00 13.2K May 20, 2021 Direct F1
transaction ALXN Common Stock, par value $.0001 per share Award $0 +673 +5.08% $0.00 13.9K May 20, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the first anniversary of the grant date.
F2 Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu ofthe annual cash retainer that the director was entitled to receive for service as a director.